Snacks
Zoom out

Stories we’re watching

Snacks / Monday, April 08, 2024

#ReleaseTheVials… TikTokers are pleading with Eli Lilly to sell single-dose vials of its weight-loss drug, Zepbound, on their own without accompanying injector pens. Zepbound, which launched late last year, is in short supply because Eli Lilly can’t make the pens fast enough. It joins similar drugs on the FDA’s shortage list, including Eli Lilly’s Mounjaro and Novo Nordisk’s Wegovy. Pharma cos are looking to scale up production as retailers like Costco start offering access to scripts. Meantime, the FDA has warned folks about sketchy knockoffs.

Block your boss… California is mulling a “right to disconnect” bill that would guarantee salaried workers the right to ignore calls, texts, emails, and DMs from their employers after work. The pandemic eroded work-life norms, with over half of US workers saying they answer work messages outside paid hours. It’d be the US’s first right-to-disconnect law, though countries including Ireland, France, and Australia already have them in place. Elsewhere in office law, Independent Sen. Bernie Sanders last month intro’d a 32-hour-workweek bill in the Senate.

Get Your News

Subscribe and thrive

Snacks provides fresh takes on the financial news you need to start your day. Chartr provides data visualizations on business, entertainment, and society. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.